These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 28428054)
1. Modified nanoparticle mediated IL-12 immunogene therapy for colon cancer. Liu X; Gao X; Zheng S; Wang B; Li Y; Zhao C; Muftuoglu Y; Chen S; Li Y; Yao H; Sun H; Mao Q; You C; Guo G; Wei Y Nanomedicine; 2017 Aug; 13(6):1993-2004. PubMed ID: 28428054 [TBL] [Abstract][Full Text] [Related]
2. Powerful anti-colon cancer effect of modified nanoparticle-mediated IL-15 immunogene therapy through activation of the host immune system. Liu X; Li Y; Sun X; Muftuoglu Y; Wang B; Yu T; Hu Y; Ma L; Xiang M; Guo G; You C; Gao X; Wei Y Theranostics; 2018; 8(13):3490-3503. PubMed ID: 30026861 [No Abstract] [Full Text] [Related]
3. Dual-mRNA Delivery Using Tumor Cell Lysate-Based Multifunctional Nanoparticles as an Efficient Colon Cancer Immunogene Therapy. Wang K; Gao Y; Wu S; Zhang J; Zhu M; Chen X; Fu X; Duan X; Men K Int J Nanomedicine; 2024; 19():4779-4801. PubMed ID: 38828196 [TBL] [Abstract][Full Text] [Related]
4. Mice vaccination with interleukin 12-transduced colon cancer cells potentiates rejection of syngeneic non-organ-related tumor cells. Adris S; Chuluyan E; Bravo A; Berenstein M; Klein S; Jasnis M; Carbone C; Chernajovsky Y; Podhajcer OL Cancer Res; 2000 Dec; 60(23):6696-703. PubMed ID: 11118055 [TBL] [Abstract][Full Text] [Related]
5. Folate-Modified Lipoplexes Delivering the Interleukin-12 Gene for Targeting Colon Cancer Immunogene Therapy. Luo M; Liang X; Luo ST; Wei XW; Liu T; Ren J; Ma CC; Yang YH; Wang BL; Liu L; Song XR; He ZY; Wei YQ J Biomed Nanotechnol; 2015 Nov; 11(11):2011-23. PubMed ID: 26554159 [TBL] [Abstract][Full Text] [Related]
6. Targeting EZH2 for glioma therapy with a novel nanoparticle-siRNA complex. Wang X; Hua Y; Xu G; Deng S; Yang D; Gao X Int J Nanomedicine; 2019; 14():2637-2653. PubMed ID: 31043779 [TBL] [Abstract][Full Text] [Related]
7. Local and Systemic Delivery of Interleukin-12 Gene by Cationic Micelles for Cancer Immunogene Therapy. Men K; Huang R; Zhang X; Zhang R; Zhang Y; He M; Tong R; Yang L; Wei Y; Duan X J Biomed Nanotechnol; 2018 Oct; 14(10):1719-1730. PubMed ID: 30041719 [TBL] [Abstract][Full Text] [Related]
8. Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer. Tamura T; Nishi T; Goto T; Takeshima H; Dev SB; Ushio Y; Sakata T Hum Gene Ther; 2001 Jul; 12(10):1265-76. PubMed ID: 11440620 [TBL] [Abstract][Full Text] [Related]
9. Treating colon cancer with a suicide gene delivered by self-assembled cationic MPEG-PCL micelles. Duan X; Wang P; Men K; Gao X; Huang M; Gou M; Chen L; Qian Z; Wei Y Nanoscale; 2012 Apr; 4(7):2400-7. PubMed ID: 22388488 [TBL] [Abstract][Full Text] [Related]
10. Delivery siRNA with a novel gene vector for glioma therapy by targeting Gli1. Zhou P; Cao Y; Liu X; Yu T; Xu Q; You C; Gao X; Wei Y Int J Nanomedicine; 2018; 13():4781-4793. PubMed ID: 30214189 [TBL] [Abstract][Full Text] [Related]
11. Reprogrammed chondrocytes engineered to produce IL-12 provide novel ex vivo immune-gene therapy for cancer. Tada H; Kishida T; Fujiwara H; Kosuga T; Konishi H; Komatsu S; Shiozaki A; Ichikawa D; Okamoto K; Otsuji E; Mazda O Immunotherapy; 2017 Mar; 9(3):239-248. PubMed ID: 28231722 [TBL] [Abstract][Full Text] [Related]
12. Functionalized DMP-039 Hybrid Nanoparticle as a Novel mRNA Vector for Efficient Cancer Suicide Gene Therapy. Gao Y; Men K; Pan C; Li J; Wu J; Chen X; Lei S; Gao X; Duan X Int J Nanomedicine; 2021; 16():5211-5232. PubMed ID: 34366664 [TBL] [Abstract][Full Text] [Related]
13. Cationic Polyphosphazene Vesicles for Cancer Immunotherapy by Efficient in Vivo Cytokine IL-12 Plasmid Delivery. Gao M; Zhu X; Wu L; Qiu L Biomacromolecules; 2016 Jun; 17(6):2199-209. PubMed ID: 27192398 [TBL] [Abstract][Full Text] [Related]
14. Single Micelle Vectors based on Lipid/Block Copolymer Compositions as mRNA Formulations for Efficient Cancer Immunogene Therapy. Li J; Men K; Gao Y; Wu J; Lei S; Yang Y; Pan H Mol Pharm; 2021 Nov; 18(11):4029-4045. PubMed ID: 34559545 [TBL] [Abstract][Full Text] [Related]
15. Delivering instilled hydrophobic drug to the bladder by a cationic nanoparticle and thermo-sensitive hydrogel composite system. Men K; Liu W; Li L; Duan X; Wang P; Gou M; Wei X; Gao X; Wang B; Du Y; Huang M; Chen L; Qian Z; Wei Y Nanoscale; 2012 Oct; 4(20):6425-33. PubMed ID: 22955255 [TBL] [Abstract][Full Text] [Related]
16. Specific cell targeting with APRPG conjugated PEG-PLGA nanoparticles for treating ovarian cancer. Wang Y; Liu P; Duan Y; Yin X; Wang Q; Liu X; Wang X; Zhou J; Wang W; Qiu L; Di W Biomaterials; 2014 Jan; 35(3):983-92. PubMed ID: 24176193 [TBL] [Abstract][Full Text] [Related]
17. Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells. Kim TH; Jin H; Kim HW; Cho MH; Cho CS Mol Cancer Ther; 2006 Jul; 5(7):1723-32. PubMed ID: 16891458 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of colon tumor growth by IL-15 immunogene therapy. He X; Li W; Wang Y; Hou L; Zhu L Mol Med Rep; 2012 Jan; 5(1):96-102. PubMed ID: 21956355 [TBL] [Abstract][Full Text] [Related]
19. Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A. Zhang L; Gao X; Men K; Wang B; Zhang S; Qiu J; Huang M; Gou M; Huang N; Qian Z; Zhao X; Wei Y Int J Nanomedicine; 2011; 6():2419-27. PubMed ID: 22072877 [TBL] [Abstract][Full Text] [Related]
20. Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma. Mendiratta SK; Quezada A; Matar M; Thull NM; Bishop JS; Nordstrom JL; Pericle F Hum Gene Ther; 2000 Sep; 11(13):1851-62. PubMed ID: 10986558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]